[Effect of apisatron in lumbar spinal cord diseases].
A therapeutic effect has been studied of the drug apizartron of the ESPARMA GmbH firm (Osterweddingen, Germany) in those patients presenting with damaged lumbar spine. The ointment apizartron has been shown to alleviate the pain syndrome and myotonic (spastic) reactions, with its effect having been somewhat less pronounced on radicular compression, neurodystrophic disorders, and on the arterial bloodflow of the inferior limbs. The drug is recommended for use in a complex therapy of vertebrogenic disorders of the lumbar spine.
Morozov
N V
NV
Ambartsumov
R N
RN
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D001514:Bee Venoms / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017116:Low Back Pain / Q000188:drug therapy / Q000503:physiopathology; D008161:Lumbosacral Region / Q000294:innervation / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009129:Muscle Tonus / Q000187:drug effects / Q000502:physiology; D009408:Nerve Compression Syndromes / Q000188:drug therapy / Q000503:physiopathology; D009824:Ointments; D013118:Spinal Cord Diseases / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D001514:Bee Venoms; D009824:Ointments; C032305:Apisartron